Molecular strategies and 111in-labelled somatostatin analogues in defining the management of neuroendocrine tumour disease: a new paradigm for surgical management.
- 1 June 2003
- journal article
- Published by Elsevier BV in The Surgeon
- Vol. 1 (3), 137-143
- https://doi.org/10.1016/s1479-666x(03)80092-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Novel Long-Acting Somatostatin Analog with Endocrine Selectivity: Potent Suppression of Growth Hormone But Not of InsulinEndocrinology, 2001
- Overexpression of Cyclin D1 Occurs Frequently in Human Pancreatic Endocrine TumorsJournal of Clinical Endocrinology & Metabolism, 2000
- Alterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in GastrinomasJournal of Clinical Endocrinology & Metabolism, 2000
- Gastric carcinoid expresses the gastrin autocrine pathwayBritish Journal of Surgery, 1998
- Gastric enterochromaffin-like (ECL) transformation is associated with increased expression of the G1 cell cycle regulators cyclin D1 and CDK4Gastroenterology, 1998
- Somatostatin receptor regulation of gastric enterochromaffin-like cell transformation to gastric carcinoidSurgery, 1996
- The role of transforming growth factor alpha in the enterochromaffin- like cell tumor autonomy in an African rodent mastomysGastroenterology, 1996
- The gastric enterochromaffin-like cell: An enigmatic cellular linkGastroenterology, 1996
- The Mastomys Gastric Carcinoid: Aspects of Enterochromaff in-Like Cell FunctionDigestion, 1994
- Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumorsEndocrinology, 1992